Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Researchers Propose a Portable Biomolecular Manufacturing Method

September 22, 2016

Researchers from the Wyss Institute explain a potential method for transporting and producing temperature-sensitive pharmaceuticals at a reduced cost.

Genentech Wins ISPE’s 2016 Facility of the Year Award

September 21, 2016

Genentech’s biologics drug substance plant is the overall winner of the International Society for Pharmaceutical Engineering’s 2016 FOYA Awards.

GSK Announces Plans to Address Emerging Global Health Issues

September 20, 2016

The company said it has plans to address global health challenges including vaccines, antimicrobial resistance, and preparation for future pandemics.

GE Healthcare Invests in Ireland Biopharma Manufacturing Campus

September 19, 2016

GE Healthcare’s GE BioPark Cork will hold four KUBio manufacturing facilities; GE will also collaborate with NIBRT for biopharmaceutical training.

3M™ Intelligent Control Inhaler

September 14, 2016

Merck KGaA Joins the DiViNe Project

September 14, 2016

The project aims to address challenges facing the development, manufacture, and delivery of vaccines.

Biosimilars Face Repercussions of Drug Pricing Debate

September 12, 2016

Concerns have emerged that continued growth in the biosimilars market could be limited by mounting pressure to push down on prescription drug outlays.

FDA’s Proposed Generic-Drug Labeling Rule: Ensuring Efficiency and Compliance

September 09, 2016

If FDA’s proposed generic-drug labeling rule is passed in 2017, generic drug companies would need documented processes for safety tracking and label updates.

Common Deficiencies in ANDAs for Dermatologic Drug Products

September 02, 2016

Companies may potentially accelerate the approval of generic drugs by avoiding deficiencies in ANDA submissions.

Taking a Closer Look at Parenteral Contaminants

September 02, 2016

Visual inspection of parenteral vials is the first step in a root cause investigation.